Home › Funds › ADAMSBROWN WEALTH CONSULTANTS LLC › PPH

ADAMSBROWN WEALTH CONSULTANTS LLC position in PPH

VANECK PHARMACEUTICAL ETF

ADAMSBROWN WEALTH CONSULTANTS LLC reported holding 101,704 shares of PPH (VANECK PHARMACEUTICAL ETF) in its Q3 2026 13F filing — a position valued at US$11.1M, representing 2.03% of its reported portfolio and ranking #15 among its reported holdings. ADAMSBROWN WEALTH CONSULTANTS LLC has disclosed PPH holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)101.70K sh
Reported value held$11.13M
Portfolio Weight2.03%
First reportedQ3 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ADAMSBROWN WEALTH CONSULTANTS LLC's PPH position evolved

ADAMSBROWN WEALTH CONSULTANTS LLC first disclosed a stake in PPH in Q3 2024 at 73,972 shares (US$7.0M). The position peaked in Q2 2025 at 195,976 shares, worth US$17.2M. Across 9 filings, ADAMSBROWN WEALTH CONSULTANTS LLC increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 101,704 shares valued at US$11.1M — a reduction of -52,410 shares quarter over quarter.. Notable position changes include a 102% increase in Q4 2024 (shares rose 6% over the following quarter), a 30% trim in Q3 2025 (shares rose 14% over the following quarter), a 34% trim in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 73.97K $7.03M New
Q4 2024 149.63K $12.91M Add
Q1 2025 174.90K $15.94M Add
Q2 2025 195.98K $17.24M Add
Q3 2025 136.90K $12.37M Reduce
Q4 2025 143.04K $14.76M Add
Q1 2026 148.81K $15.46M Add
Q2 2026 154.11K $16.85M Add
Q3 2026 101.70K $11.13M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PPH and 13F data

PPH (VANECK PHARMACEUTICAL ETF) is a company whose sector is not yet classified in our data. 20 other funds we track also report a position in PPH — the largest reported positions include J.Safra Asset Management Corp (US$35.9M), Avalon Trust Co (US$27.8M), Rye Brook Capital LLC (US$7.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PPH

All PPH fund holders →

FAQ

How long has ADAMSBROWN WEALTH CONSULTANTS LLC held PPH?

ADAMSBROWN WEALTH CONSULTANTS LLC has disclosed PPH holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is ADAMSBROWN WEALTH CONSULTANTS LLC's current position in PPH?

As of Q3 2026, ADAMSBROWN WEALTH CONSULTANTS LLC holds 101.70K shares of PPH (VANECK PHARMACEUTICAL ETF), valued at $11.13M, representing 2.03% of its reported portfolio and ranking #15.

Has ADAMSBROWN WEALTH CONSULTANTS LLC been buying or selling PPH?

In the latest 13F filing (Q3 2026), ADAMSBROWN WEALTH CONSULTANTS LLC reduced its position in PPH. The position peaked in Q2 2025 at 195.98K shares.

Which other funds hold PPH?

Other major institutional holders of PPH include J.Safra Asset Management Corp, Avalon Trust Co, Rye Brook Capital LLC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.